Posted on 10/30/18
TripleCare Strengthens Partnership with Mission Health
NEW YORK & TUCKER, Ga.--(BUSINESS WIRE)--TripleCare, a national provider of telemedicine-based healthcare services to skilled nursing facilities (SNFs), announced today it has introduced its telemedicine services . . .
Posted on 10/30/18
Eagle Pharmaceuticals Announces Results of Study for Fulvestrant
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced that the Company’s fulvestrant formulation has not met the primary bioequivalence endpoints evaluating Eagle’s formulation compared . . .
Posted on 10/30/18
Eagle Pharmaceuticals Commences $50 Million Accelerated Share Repurchase
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today provided preliminary financial results and announced that its Board of Directors has approved a new stock repurchase program . . .
Posted on 10/30/18
Eagle Pharmaceuticals Commences $50 Million Accelerated Share Repurchase
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today provided preliminary financial results and announced that its Board of Directors has approved a new stock repurchase program . . .
Posted on 10/30/18
Aetna Reports Third-Quarter 2018 Results
HARTFORD, Conn.--(BUSINESS WIRE)--Aetna (NYSE: AET) announced third-quarter 2018 net income(1) of $1.0 billion, or $3.03 per share. Adjusted earnings(2) for third-quarter 2018 were $977 million, or . . .
Posted on 10/30/18
Insmed Reports Third Quarter 2018 Financial Results and Provides Business Update
BRIDGEWATER, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious . . .
Posted on 10/30/18
Antares Pharma to Report Third Quarter 2018 Financial and Operating Results
EWING, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its third quarter 2018 financial results and recent . . .
Posted on 10/30/18
Celgene Beats and Raises, but It's All About the Pipeline
Celgene (NASDAQ:CELG) continues to post solid revenue gains from its current drugs, but with generics of top-selling Revlimid slated to hit the market starting in 2022, . . .
Posted on 10/29/18
Novartis wins esteemed Prix Galien Foundation Best Biotechnology Product Award for CAR-T cell therapy, Kymriah
Novartis was awarded the 2018 Prix Galien USAAward for Best Biotechnology Product for Kymriah (tisagenlecleucel) following its first-in-class approval by the US Food and Drug Administration . . .
Posted on 10/29/18
Pfizer Announces Clinical Development Agreement with Novartis
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that it has entered into a non-exclusive clinical development agreement with Novartis (NYSE: NVS) to investigate one or more . . .
Posted on 10/29/18
HealthCare.com Named to Red Herring's Top 100 Global Technology Company List
NEW YORK--(BUSINESS WIRE)--HealthCare.com has been recognized as a Top 100 Global Technology Company by Red Herring, a respected independent company that curated and evaluated more than . . .
Posted on 10/29/18
Johnson & Johnson Consumer Aligns To Big Goals In Environmental Sustainability, Signs New Plastics Economy Global Commitment
Johnson & Johnson Consumer, Inc. today announced the company is joining an ambitious effort to move the world closer to a circular economy in which plastic . . .
Posted on 10/29/18
Johnson & Johnson Loses Zytiga Patent Dispute, Appeal Planned
Johnson & Johnson (NYSE:JNJ) reports that a New Jersey district court ruled that all claim asserted under its U.S. Patent No. 8,822,438 are invalid, removing a . . .
Posted on 10/29/18
Better Buy: Cara Therapeutics, Inc. vs. Scotts Miracle-Gro Company
What do Cara Therapeutics, Inc. (NASDAQ:CARA) and Scotts Miracle-Gro (NYSE:SMG)have in common? Very little.Both are often categorized as marijuana stocks. Cara receives the designation because of . . .
Posted on 10/29/18
This Big Pharma Bet Isn't Paying Off Yet -- and It's Costing You
You probably wouldn't care too much if your neighbor bought 1,000 lottery tickets that didn't win. But it might be a different story if his bet . . .
Posted on 10/28/18
Regeneron Ranked #1 Biopharma Employer for Sixth Time by Science Magazine
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Science magazine has named the company the world's number one employer in its annual survey of the biotech . . .
Posted on 10/26/18
Merck & Co Inc (MRK) Q3 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOLMerck & Co Inc (NYSE:MRK)Q3 2018 Earnings Conference CallOct. 25, 2018, 8:00 a.m. ETContents: Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning, my . . .
Posted on 10/26/18
Celgene Corp (CELG) Q3 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Celgene Corp (NASDAQ:CELG)Q3 2018 Earnings Conference CallOct. 25, 2018, 9:00 a.m. ETContents: Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood morning and welcome to . . .
Posted on 10/26/18
Bristol-Myers Squibb Co (BMY) Q3 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Bristol-Myers Squibb Co (NYSE:BMY)Q3 2018 Earnings Conference CallOct. 25, 2018, 10:30 a.m. ETContents: Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood day, and welcome . . .
Posted on 10/26/18
Synergy Pharmaceuticals Provides Business Update
NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) (the “Company” or “Synergy”), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today provided . . .
Posted on 10/25/18
Bristol-Myers Squibb Reports Third Quarter Financial Results
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the third quarter of 2018 which were highlighted by strong sales and operating performance along with . . .
Posted on 10/25/18
Merck Announces Third-Quarter 2018 Financial Results
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2018.“We built on . . .
Posted on 10/25/18
Merck Announces Increased Fourth-Quarter Dividend and $10 Billion Share Repurchase Authorization
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that its Board of Directors has approved a 15 percent increase . . .
Posted on 10/25/18
Celgene Reports Third Quarter 2018 Operating and Financial Results
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) reported net product sales of $3,890 million for the third quarter of 2018, an 18 percent increase from the same period . . .
Posted on 10/25/18
Don't Sell Johnson & Johnson
SummaryA recent article says JNJ should be sold because the talc lawsuits represent too big a danger at the current price.The threat to J&J from the . . .

